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Congenital cranial dysinnervation disorders (CCDDs) are a heterogeneous group of
neurodevelopmental phenotypes caused by a primary disturbance of innervation due
to deficient, absent, or misguided cranial nerves. Although some CCDDs genes are
known, several clinical phenotypes and their aetiologies remain to be elucidated. We
describe a 12-year-old boy with hypotonia, developmental delay, sensorineural hear-
ing loss, and keratoconjunctivitis due to lack of corneal reflex. He had a long expres-
sionless face, severe oromotor dysfunction, bilateral agenesis/severe hypoplasia of
the VIII nerve with marked atresia of the internal auditory canals and cochlear laby-
rinth malformation. Trio-exome sequencing identified a homozygous loss of function
variant in the NEUROG1 gene (NM_006161.2: c.202G > T, p.Glu68*). NEUROG1 is
considered a causal candidate for CCDDs based on (i) the previous report of a patient
with a homozygous gene deletion and developmental delay, deafness due to absent
bilateral VIII nerves, and severe oromotor dysfunction; (ii) a second patient with a
homozygous NEUROG1 missense variant and corneal opacity, absent corneal reflex
and intellectual disability; and (iii) the knockout mouse model phenotype which highly
resembles the disorder observed in humans. Our findings support the growing com-
pelling evidence that loss of NEUROG1 leads to a very distinctive disorder of cranial
nerves development.
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1 | INTRODUCTION
The abnormal development of the cranial nerves can have a genetic
basis and result in several phenotypes including recessive hearing loss
and congenital cranial dysinnervation disorders (CCDDs), such as
Moebius syndrome, Duane syndrome, Marcus Gunn jaw-winking syn-
drome, congenital ptosis, and congenital fibrosis of extraocular
muscles.1 These disorders are heterogeneous and incompletely
understood.
NEUROG1 encodes Ngn1 which is a basic helix–loop–helix tran-
scription factor essential for the formation of the proximal cranial sen-
sory ganglia for cranial nerves V and VIII. Ngn1 induces neurogenesis
and inhibits the differentiation of neural stem cells into astrocytes by
two independent mechanisms. Initially expressed in the epithelium of
the trigeminal and otic placodes prior to the onset of neuroblast
migration, Ngn1 dimerizes with ubiquitous bHLH proteins and triggersJuliette Dupont and José Pedro Vieira contributed equally to this study.
Received: 11 November 2020 Revised: 5 January 2021 Accepted: 8 January 2021
DOI: 10.1111/cge.13922
588 © 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Clinical Genetics. 2021;99:588–593.wileyonlinelibrary.com/journal/cge
a cascade of downstream bHLH factors, including NeuroD, MATH3
and NSCL1, leading to neuronal differentiation. In addition, Ngn1
inhibits astrocyte differentiation by sequestering the CREB-binding
protein transcription complex away from astrocyte differentiation
genes and by inhibiting the activation of STAT transcription factors
necessary for gliogenesis.2,3
We report a patient with mild intellectual disability, epilepsy,
deafness, peripheral sensory neuropathy, loss of facial sensation,
abnormal development of sensory cranial nerves V and VIII, and a
homozygous putative loss of function variant in NEUROG1. The
patient's phenotype is highly similar to two previously reported cases
with homozygous variants in NEUROG1.4,5 Although NEUROG1 is not
yet associated with a human phenotype in OMIM, our findings sup-
port a causal link between NEUROG1 and a CCDD.
2 | PATIENT AND METHODS
Clinical data was obtained from clinical files and a detailed physical
exam was performed. All procedures had the approval of the ethics
committee of Hospital de Dona Estefânia, Centro Hospitalar
Universitário de Lisboa Central.
Informed written consent was obtained from the patient's par-
ents. All genetic studies were performed for diagnostic purposes.
Clinical data from our patient was compared with published data
from two other patients described in the medical literature with
homozygous variants in NEUROG1.4,5
The patient and his parents were exome sequenced at
CENTOGENE AG (Rostock, Germany), as previously described.6
Libraries were sequenced on an Illumina Hiseq 4000 with 150 bp
paired end sequencing. Variant calling was performed using GATK.
Variants with a phred-scaled quality score > 2157 and a MAF of <1%
were retained for analysis. Variants were further filtered based on
zygosity and segregation in the family. The database CentoMD®8 was
queried for rare variants (<1%) in NEUROG1 (14 August 2020) and the
resulting data was filtered taking into consideration an autosomal
recessive mode of inheritance and the impact of the variant (non-
synonymous).
3 | CLINICAL REPORT
Our patient is a 12-year-old male, the only child of healthy parents of
Portuguese origin with no known consanguinity.
Gestation was uneventful and delivery was by caesarean
section at term due to feto-pelvic disproportion. Birth weight was
3395 g (50th centile), length 51.5 cm (50–75th centile) and head cir-
cumference 34 cm (25–50th centile). Apgar score was 9/10.
He was globally hypotonic since birth. At 22 days he was admit-
ted to hospital due to hypotonia and feeding difficulties requiring
naso-gastric feeds.
He had global developmental delay with no history of regression.
He sat alone at 18 months and walked independently at 3 years. He
never developed expressive language and Brainstem Auditory Evoked
Responses at 15 months confirmed profound bilateral sensorineural
deafness. He was educated in a school for deaf children and learnt to
communicate using sign language.
Ophthalmology review at 18 months was normal; however, at
24 months he had keratoconjuntivitis and lost vision in his right eye.
Around the age of five he manifested insomnia, hyperkinesia and self-
injurious behavior (hitting his face and eyes). When he was seven he
also presented brief bilateral myoclonic seizures.
At the age of 10 his global IQ (evaluated with appropriate tests
for deaf children) was 62, and he manifested major problems with
attention, short term memory and abstract thinking.
On physical examination at 10 years his stature was 129 cm
(10th centile), weight was 24 kg (third centile), and head circumfer-
ence 52 cm (25th centile). He had a long, asymmetric and expression-
less face with open mouth (Figure 1). Long palpebral fissures, high
arched eyebrows, ocular leucoma in the right eye, and an arched, and
narrow palate were noted (Figure 1). Neurological examination rev-
ealed deafness, apparent bilateral loss of facial sensation, and absence
of corneal reflexes. Ocular motility was normal. Facial movements in
emotional expressions were asymmetric with the mouth deviating to
the left. Lower cranial nerve examination was normal. Gait was
unsteady with no preponderant side. Muscle power and tone were
normal. Stretch reflexes were absent and there was a bilateral flexor
plantar response.
Extensive neurometabolic investigations, abdominal ultra-
sound and echocardiogram were all normal. EMG at 5 years was
compatible with an axonal sensory neuropathy. Blink reflexes
were absent bilaterally. Brain MRI revealed hypoplasia of cranial
nerves V and VIII, marked atresia of the internal auditory canal
and hypoplasia of the cochlear labyrinth, bilaterally (Figure 2). The
brainstem, cerebellum and cerebral hemispheres were normal. The
EEG documented bilateral rolandic spikes with normal background
activity.
Array CGH showed no relevant copy number variants. Previ-
ous molecular testing of DMPK and SLC52A1/SLC52A2/SLC52A3
were also negative. Trio-exome performed for diagnostic purposes
(CENTOGENE AG) did not detect relevant variants in morbid
genes. An extended search to include genes not previously associ-
ated with human disease identified a novel nonsense homozygous
variant in NEUROG1 (NM_006161.2): c.202G > T, p.Glu68*. The
gene contains only one exon, and there is only one known
NEUROG1 protein isoform. The variant introduces a premature
termination codon, leading most likely to a truncated protein.
Schematic from BAM files showing the location of the variant and
the bHLH protein domain is depicted in Figure S1. Both parents
were heterozygous for the NEUROG1 variant thus confirming
homozygosity in the index case. There are only a few LoF variants
in NEUROG1 reported in gnomAD, none in homozygosity (acessed
August 14, 2020). Similarly, a search in CENTOGENE data reposi-
tories (PMID: 28116331) did not identify additional individuals
with homozygous or combined heterozygous LoF variants in
this gene.
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4 | DISCUSSION
Several genes related to neuronal development are currently linked to
congenital cranial dysinnervation disorders (PLXND1 and REV3L for
Moebius syndrome, MAFB, HOXA1, SALL4 and CHN1 for Duane syn-
drome, ROBO3 for horizontal gaze palsy with progressive scoliosis,
and PHOX2A, KIF21A, TUBB3 and TUBB2B for congenital fibrosis of
extraocular muscles). These disorders are believed to result from a pri-
mary disruption of innervation due to the abnormal development of
cranial nerves.9-13
In the developing CNS the formation of trigeminal and
vestibulocochlear nerves requires the activity of NEUROG1.2,3 The
development of dorsal root ganglion cells is likewise dependent on
NEUROG1, which also commits neuronal progenitor cells in the olfac-
tory bulb, cerebral cortex, hippocampus, thalamus, brainstem and cer-
ebellum.14 The gene NEUROG1 and protein Ngn1 have been well
studied in vertebrate animal models.15,16
Ma et al. (1998) generated Ngn1-null mice embryos showing
complete absence of trigeminal and otic placode–derived vestibulo-
cochlear ganglia, apparent truncation of cranial nerve V, and loss of
expression of Ngn1 downstream bHLH factors, including NeuroD, Math3
and NSCL1, in mutant otic and trigeminal placodes.
Present knowledge about the biology of Ngn1 and the pheno-
type of the animal model are concordant with the clinical features
we report here. Our patient's deafness, hypoplastic cranial nerve
VIII, bilateral atresia of the internal auditory canals, and hypoplasia
of the cochlear labyrinth match the observations in Neurog1
knock-out mice.15,16 Ngn1-null mutants had no vestibulocochlear
ganglion, no VIIIth nerve afferent, efferent and autonomic fibres,
small abnormal inner ear and cochlear hypoplasia. Our patient's
hypoplasia of cranial nerve V, lack of corneal reflexes, and facial
anaesthesia were associated with oromotor dysfunction and led to
a corneal traumatic lesion. In mice lacking Ngn1 inability to suckle
caused early lethality. In the human patients medical resources
such as parenteral feeding, nasogastric tube and interventions
focusing on strengthening oromotor function helped overcome
equivalent feeding difficulties.
F IGURE 1 Frontal and profile
views of our patient with a
homozygous nonsense variant in
NEUROG1 gene at 10 years: (A) long
expressionless face, elongated
palpebral fissures, facial asymmetry,
deviation of the mouth to the left
when smiling with loss of the
nasolabial fold on the right-side;
(B) inability to close the mouth [Colour
figure can be viewed at
wileyonlinelibrary.com]
F IGURE 2 T2 weighted brain MRI, Constructive Interference in
Steady State (CISS) sequence: (A),(B) Coronal view of the patient's
trigeminal nerves (A) showing they are much thinner than in a normal
control at the same age (B); (C),(D) Axial view of the patient's trigeminal
nerves (C) in comparison with a normal control (D) with the dashed
arrows pointing at the trigeminal ganglion; (E) Axial view showing a
stenotic internal auditory canal (arrow) and hypoplastic cochlea (dashed
arrow) [Colour figure can be viewed at wileyonlinelibrary.com]
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NEUROG1 is involved in neurogenesis in the central nervous sys-
tem including the neocortex.17 Although the intellectual disability pre-
sent in our patient may be partly ascribed to deafness and sensorial
deprivation, and the self-injurious behavior likewise attributed to
abnormal sensation in the trigeminal territory, it is likely these fea-
tures, as well as epilepsy, are manifestations of abnormal cortical
development. NEUROG1 promotes sensory neuron differentiation in
dorsal root ganglia.18 Thus, delayed motor development, and the find-
ings on nerve conduction studies compatible with a subclinical axonal
sensory neuropathy in our patient, may also be related to the
NEUROG1 gene defect.
In 2013, Schroder et al.4 reported one patient with dysmorphic
features, mild intellectual disability, deafness, severe hypoplasia of the
vestibulo-cochlear nerves, narrow internal auditory canal, hypoplastic
cochlea, and oromotor dysfunction. This patient had a homozygous
microdeletion in chromosome 5 including all exons and corresponding
promoter regions of the NEUROG1, TIFAB and DCNP1 genes. The
authors claimed the phenotype in Neurog1 knock-out mice was in
agreement with the clinical and radiological findings in their patient.
Moreover, they observed a balance disorder in their patient, which
they linked to the absence of utriculosaccular ducts in Ngn1-null mice.
Malfunction of cranial nerve V was assumed, but loss of sensation in
this nerve's territory or its absence on brain MRI were not described.
Based on the reported phenotype of Ngn1-null mutant mice, Schroder
et al. proposed NEUROG1 as a new candidate gene for a congenital
cranial dysinnervation disorder including cranial nerves V and VIII, and
excluded TIFAB and DCNP1 as causative.19-21
Finally, in 2015, Yavarna et al. identified a patient with corneal
opacity, absent corneal reflexes and intellectual disability who had a
homozygous missense variant in NEUROG1: c.347G > T,
p. Arg116Leu.5 A summary of the clinical phenotypes of these
patients is shown in Table 1.
Taken together, the very unusual combination of clinical features,
and the striking similarity in findings between these three patients
and the characteristics of the knock-out mouse model, provide com-
pelling evidence that loss of NEUROG1 is causing CCDDs in humans.
Our data strengthens the association of NEUROG1 with a very distinc-
tive phenotype that comprises features related to hypoplasia/absence
of the Vth and VIIIth cranial nerves, mild intellectual disability and,
possibly, a wider clinical spectrum including manifestations such as
TABLE 1 Comparison of clinical data between Schroder and Yavarnas's cases and our patient
Schroder et al., 2013 Yavarna et al., 2015 Our patient
Neonatal period
Normal birth parameters Yes nk Yes
Poor sucking and swallowing nk nk Yes
Global hypotonia Yes nk Yes
Torticollis Yes nk No
Growth and development
Weight and height between 3rd-97th centiles Yes (weight 50th centile and
height 5th centile)
nk Yes (weight 3th centile and
height 10th centile)
Head circumference between 3rd-97th centiles Yes (75th centile) nk Yes (25th centile)
DD/ID Yes (mild) Yes (mild) Yes (mild)
Neurological involvement
Lagopthalmos, absent corneal reflex nk Yes Yes
Bilateral loss of facial sensation nk nk Yes
Bilateral sensorineural hearing loss Yes (profound) nk Yes (profound)
Oromotor dysfunction Yes (increased salivation,
inability to chew, mashed diet)
nk Yes (chewing/swallowing
difficulties, unable to close
the mouth)
Balance disorder Yes nk Yes (ataxic gait)
Muscle weakness Yes nk No
Epilepsy No nk Yes (brief bilateral
myoclonic seizures)
Craniofacial features
Cranial conformation plagioscaphocephaly nk plagiocephaly
Long face Yes nk Yes
Lack of facial mimicry Yes nk Yes
Facial asymmetry Yes nk Yes
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epilepsy and axonal sensory neuropathy; and contributes to a better
understanding and classification of these disorders.
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